Table 1

CKD classification by MDRD and CKD-EPI

eGFRMDRD<1515–2930–5960–89>90Totals
CKD-EPICKD stage54321/0
A. Numbers
 <15532853000381
 15–29441812368002184
 30–59303021 936973022 939
 60–89200304871 565362178 234
 >901/000024 07047 86371 933
 Totals332189525 35296 60851 484175 671
B. Percentages
 <1550.1870.030000.217
 15–2940.0021.0310.209001.242
 30–59300.01712.4880.554013.058
 60–892001.73540.7382.06144.534
 >901/000013.70227.24640.948
 Totals0.1891.07814.43154.99429.307100
  • Columns indicate results obtained using the MDRD formula and show the redistribution of patients in these CKD groups on the basis of eGFR (ml/min/1.73m2) when assessed using the CKD-EPI formula, shown in rows. ‘A’ shows the numbers of patients in each group and ‘B’ shows these numbers as a percentage of the total number of those tested. Figures in bold indicate those who do not change CKD category on the basis of eGFR with a change from the MDRD to the CKD-EPI formula. Below these, underlined figures indicate the numbers who move into a better CKD category and above and italicised figures indicate the numbers of patients who move into a worse CKD stage. Both CKD stages 1 and 2 require a structural or other abnormality in addition to the eGFR criteria.

  • CKD, chronic kidney disease; CKD-EPI, Chronic Kidney Disease-Epidemiology Collaboration; eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease.